Comparison of EQ-5D and SF-6D utilities in Pompe disease

被引：0
作者：
T. A. Kanters
W. K. Redekop
M. E. Kruijshaar
A. T. van der Ploeg
M. P. M. H. Rutten-van Mölken
L. Hakkaart
机构：
[1] Erasmus University Rotterdam,Department of Health Policy and Management, Institute for Medical Technology Assessment
[2] Erasmus MC University Medical Center,Center for Lysosomal and Metabolic Diseases
[3] Erasmus MC University Medical Center Rotterdam,Division of Metabolic Diseases and Genetics, Department of Pediatrics
来源：
Quality of Life Research | 2015年 / 24卷
关键词：
Preference-based measure of health; EQ-5D; SF-6D; Orphan disease, Pompe disease;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：837 / 844
页数：7
相关论文
共 141 条
[1]  
Haffner ME(2006)Adopting orphan drugs—two dozen years of treating rare diseases New England Journal of Medicine 354 445-447
[2]  
Schey C(2011)Estimating the budget impact of orphan medicines in Europe: 2010–2020 Orphanet Journal of Rare Diseases 6 62-42
[3]  
Milanova T(2007)Assessing the economic challenges posed by orphan drugs International Journal of Technology Assessment in Health Care 23 36-1353
[4]  
Hutchings A(2008)Pompe’s disease The Lancet 372 1342-716
[5]  
Drummond MF(1999)Frequency of glycogen storage disease type II in the Netherlands: Implications for diagnosis and genetic counselling European Journal of Human Genetics 7 713-136
[6]  
Wilson DA(2011)Rate of progression and predictive factors for pulmonary outcome in children and adults with Pompe disease Molecular Genetics and Metabolism 104 129-706
[7]  
Kanavos P(2007)Late onset Pompe disease: Clinical and neurophysiological spectrum of 38 patients including long-term follow-up in 18 patients Neuromuscular Disorders 17 698-117
[8]  
Ubel P(2012)Clinical features and predictors for disease natural progression in adults with Pompe disease: A nationwide prospective observational study Orphanet Journal of Rare Diseases 7 88-1692
[9]  
Rovira J(2009)Rate of disease progression during long-term follow-up of patients with late-onset Pompe disease Neuromuscular Disorders 19 113-1052
[10]  
Van der Ploeg AT(2004)Late-onset Pompe disease primarily affects quality of life in physical health domains Neurology 63 1688-1236
12345678910